Apollon Wealth Management LLC purchased a new stake in Nuveen ESG Large-Cap Value ETF (BATS:NULV – Free Report) in the 4th ...

“I’m not opposed to the concept of equity financing, I believe that preserving equity is fundamental to preserving a Founder’s vision,” said Ryan Saadi, Founder and CEO of Tevogen Bio. “From a ...

On August 15, Tevogen Bio entered into a definitive agreement for a $6 million Series C Preferred Stock investment (“Series C”). The shares of the Series C have a 7.5% annual dividend and are ...

US investment manager Nuveen is considering selling a minority stake in its private-capital arm, Nuveen Private Capital, ...